Hyperchloremic Metabolic Acidosis due to Cholestyramine: A Case Report and Literature Review.

Case Rep Nephrol

University of Toronto and University Health Network, Toronto General Hospital, Room 8N-842, 200 Elizabeth Street, Toronto, ON, Canada M5G 2C4.

Published: October 2015

Cholestyramine is a bile acid sequestrant that has been used in the treatment of hypercholesterolemia, pruritus due to elevated bile acid levels, and diarrhea due to bile acid malabsorption. This medication can rarely cause hyperchloremic nonanion gap metabolic acidosis, a complication featured in this report of an adult male with concomitant acute kidney injury. This case emphasizes the caution that must be taken in prescribing cholestyramine to patients who may also be volume depleted, in renal failure, or taking spironolactone.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4573617PMC
http://dx.doi.org/10.1155/2015/309791DOI Listing

Publication Analysis

Top Keywords

bile acid
12
metabolic acidosis
8
hyperchloremic metabolic
4
acidosis cholestyramine
4
cholestyramine case
4
case report
4
report literature
4
literature review
4
review cholestyramine
4
cholestyramine bile
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!